Cargando…
Progress in fed-batch culture for recombinant protein production in CHO cells
ABSTRACT: Nearly 80% of the approved human therapeutic antibodies are produced by Chinese Hamster Ovary (CHO) cells. To achieve better cell growth and high-yield recombinant protein, fed-batch culture is typically used for recombinant protein production in CHO cells. According to the demand of nutri...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843118/ https://www.ncbi.nlm.nih.gov/pubmed/36648523 http://dx.doi.org/10.1007/s00253-022-12342-x |
_version_ | 1784870314141810688 |
---|---|
author | Xu, Wen-Jing Lin, Yan Mi, Chun-Liu Pang, Jing-Ying Wang, Tian-Yun |
author_facet | Xu, Wen-Jing Lin, Yan Mi, Chun-Liu Pang, Jing-Ying Wang, Tian-Yun |
author_sort | Xu, Wen-Jing |
collection | PubMed |
description | ABSTRACT: Nearly 80% of the approved human therapeutic antibodies are produced by Chinese Hamster Ovary (CHO) cells. To achieve better cell growth and high-yield recombinant protein, fed-batch culture is typically used for recombinant protein production in CHO cells. According to the demand of nutrients consumption, feed medium containing multiple components in cell culture can affect the characteristics of cell growth and improve the yield and quality of recombinant protein. Fed-batch optimization should have a connection with comprehensive factors such as culture environmental parameters, feed composition, and feeding strategy. At present, process intensification (PI) is explored to maintain production flexible and meet forthcoming demands of biotherapeutics process. Here, CHO cell culture, feed composition in fed-batch culture, fed-batch culture environmental parameters, feeding strategies, metabolic byproducts in fed-batch culture, chemostat cultivation, and the intensified fed-batch are reviewed. KEY POINTS: • Fed-batch culture in CHO cells is reviewed. • Fed-batch has become a common technology for recombinant protein production. • Fed batch culture promotes recombinant protein production in CHO cells. |
format | Online Article Text |
id | pubmed-9843118 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-98431182023-01-17 Progress in fed-batch culture for recombinant protein production in CHO cells Xu, Wen-Jing Lin, Yan Mi, Chun-Liu Pang, Jing-Ying Wang, Tian-Yun Appl Microbiol Biotechnol Mini-Review ABSTRACT: Nearly 80% of the approved human therapeutic antibodies are produced by Chinese Hamster Ovary (CHO) cells. To achieve better cell growth and high-yield recombinant protein, fed-batch culture is typically used for recombinant protein production in CHO cells. According to the demand of nutrients consumption, feed medium containing multiple components in cell culture can affect the characteristics of cell growth and improve the yield and quality of recombinant protein. Fed-batch optimization should have a connection with comprehensive factors such as culture environmental parameters, feed composition, and feeding strategy. At present, process intensification (PI) is explored to maintain production flexible and meet forthcoming demands of biotherapeutics process. Here, CHO cell culture, feed composition in fed-batch culture, fed-batch culture environmental parameters, feeding strategies, metabolic byproducts in fed-batch culture, chemostat cultivation, and the intensified fed-batch are reviewed. KEY POINTS: • Fed-batch culture in CHO cells is reviewed. • Fed-batch has become a common technology for recombinant protein production. • Fed batch culture promotes recombinant protein production in CHO cells. Springer Berlin Heidelberg 2023-01-17 2023 /pmc/articles/PMC9843118/ /pubmed/36648523 http://dx.doi.org/10.1007/s00253-022-12342-x Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Mini-Review Xu, Wen-Jing Lin, Yan Mi, Chun-Liu Pang, Jing-Ying Wang, Tian-Yun Progress in fed-batch culture for recombinant protein production in CHO cells |
title | Progress in fed-batch culture for recombinant protein production in CHO cells |
title_full | Progress in fed-batch culture for recombinant protein production in CHO cells |
title_fullStr | Progress in fed-batch culture for recombinant protein production in CHO cells |
title_full_unstemmed | Progress in fed-batch culture for recombinant protein production in CHO cells |
title_short | Progress in fed-batch culture for recombinant protein production in CHO cells |
title_sort | progress in fed-batch culture for recombinant protein production in cho cells |
topic | Mini-Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843118/ https://www.ncbi.nlm.nih.gov/pubmed/36648523 http://dx.doi.org/10.1007/s00253-022-12342-x |
work_keys_str_mv | AT xuwenjing progressinfedbatchcultureforrecombinantproteinproductioninchocells AT linyan progressinfedbatchcultureforrecombinantproteinproductioninchocells AT michunliu progressinfedbatchcultureforrecombinantproteinproductioninchocells AT pangjingying progressinfedbatchcultureforrecombinantproteinproductioninchocells AT wangtianyun progressinfedbatchcultureforrecombinantproteinproductioninchocells |